Report Detail

Medical Devices & Consumables Global and United States Hepatitis Testing Diagnosis Market Report & Forecast 2022-2028

  • RnM4420462
  • |
  • 06 April, 2022
  • |
  • Global
  • |
  • 120 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

Summary:

The purpose of hepatitis tests is to screen for and diagnose hepatitis, evaluate the liver, and to determine the underlying cause of hepatitis
Common hepatitis tests include Enzyme-linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests (RDT), Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), etc.
Market Analysis and Insights: Global and United States Hepatitis Testing Diagnosis Market
This report focuses on global and United States Hepatitis Testing Diagnosis market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Hepatitis Testing Diagnosis market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Enzyme-linked Immunosorbent Assay (ELISA) accounting for % of the Hepatitis Testing Diagnosis global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospital was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Hepatitis Testing Diagnosis market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
Global Hepatitis Testing Diagnosis Scope and Market Size
Hepatitis Testing Diagnosis market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Hepatitis Testing Diagnosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Hepatitis Testing Diagnosis market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type, the Hepatitis Testing Diagnosis market is segmented into
Enzyme-linked Immunosorbent Assay (ELISA)
Rapid Diagnostic Tests (RDT)
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Others
Segment by Application, the Hepatitis Testing Diagnosis market is segmented into
Hospital
Blood Banks
Other
Regional and Country-level Analysis
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Landscape and Hepatitis Testing Diagnosis Market Share Analysis
Hepatitis Testing Diagnosis market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Hepatitis Testing Diagnosis business, the date to enter into the Hepatitis Testing Diagnosis market, Hepatitis Testing Diagnosis product introduction, recent developments, etc.
The major vendors covered:
F. Hoffmann-La Roche
Abbott Laboratories
Siemens Healthineers AG
Bio-Rad Laboratories
Danaher Corporation
QIAGEN
BioMerieux SA
DiaSorin S.P.A.
Ortho Clinical Diagnostics
MedMira Inc
Fujirebio
Grifols
Orasure Technologies
GenMark Diagnostics
Vela Diagnostics
Epitope Diagnostics
Trivitron Healthcare
Meril Life Sciences
geneOmbio Technologies
Molbio Diagnostics


Table of Contents

    1 Study Coverage

    • 1.1 Hepatitis Testing Diagnosis Product Introduction
    • 1.2 Global Hepatitis Testing Diagnosis Outlook 2017 VS 2022 VS 2028
      • 1.2.1 Global Hepatitis Testing Diagnosis Sales in US$ Million for the Year 2017-2028
      • 1.2.2 Global Hepatitis Testing Diagnosis Sales in Volume for the Year 2017-2028
    • 1.3 United States Hepatitis Testing Diagnosis Outlook 2017 VS 2022 VS 2028
      • 1.3.1 United States Hepatitis Testing Diagnosis Sales in US$ Million for the Year 2017-2028
      • 1.3.2 United States Hepatitis Testing Diagnosis Sales in Volume for the Year 2017-2028
    • 1.4 Hepatitis Testing Diagnosis Market Size, United States VS Global, 2017 VS 2022 VS 2028
      • 1.4.1 The Market Share of United States Hepatitis Testing Diagnosis in Global, 2017 VS 2022 VS 2028
      • 1.4.2 The Growth Rate of Hepatitis Testing Diagnosis Market Size, United States VS Global, 2017 VS 2022 VS 2028
    • 1.5 Hepatitis Testing Diagnosis Market Dynamics
      • 1.5.1 Hepatitis Testing Diagnosis Industry Trends
      • 1.5.2 Hepatitis Testing Diagnosis Market Drivers
      • 1.5.3 Hepatitis Testing Diagnosis Market Challenges
      • 1.5.4 Hepatitis Testing Diagnosis Market Restraints
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Market by Type

    • 2.1 Hepatitis Testing Diagnosis Market Segment by Type
      • 2.1.1 Enzyme-linked Immunosorbent Assay (ELISA)
      • 2.1.2 Rapid Diagnostic Tests (RDT)
      • 2.1.3 Polymerase Chain Reaction (PCR)
      • 2.1.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
      • 2.1.5 Others
    • 2.2 Global Hepatitis Testing Diagnosis Market Size by Type
      • 2.2.1 Global Hepatitis Testing Diagnosis Sales in Value, by Type (2017, 2022 & 2028)
      • 2.2.2 Global Hepatitis Testing Diagnosis Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.2.3 Global Hepatitis Testing Diagnosis Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    • 2.3 United States Hepatitis Testing Diagnosis Market Size by Type
      • 2.3.1 United States Hepatitis Testing Diagnosis Sales in Value, by Type (2017, 2022 & 2028)
      • 2.3.2 United States Hepatitis Testing Diagnosis Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.3.3 United States Hepatitis Testing Diagnosis Average Selling Price (ASP) by Type (2017, 2022 & 2028)

    3 Market by Application

    • 3.1 Hepatitis Testing Diagnosis Market Segment by Application
      • 3.1.1 Hospital
      • 3.1.2 Blood Banks
      • 3.1.3 Other
    • 3.2 Global Hepatitis Testing Diagnosis Market Size by Application
      • 3.2.1 Global Hepatitis Testing Diagnosis Sales in Value, by Application (2017, 2022 & 2028)
      • 3.2.2 Global Hepatitis Testing Diagnosis Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 Global Hepatitis Testing Diagnosis Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    • 3.3 United States Hepatitis Testing Diagnosis Market Size by Application
      • 3.3.1 United States Hepatitis Testing Diagnosis Sales in Value, by Application (2017, 2022 & 2028)
      • 3.3.2 United States Hepatitis Testing Diagnosis Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 United States Hepatitis Testing Diagnosis Average Selling Price (ASP) by Application (2017, 2022 & 2028)

    4 Global Hepatitis Testing Diagnosis Competitor Landscape by Company

    • 4.1 Global Hepatitis Testing Diagnosis Market Size by Company
      • 4.1.1 Top Global Hepatitis Testing Diagnosis Manufacturers Ranked by Revenue (2021)
      • 4.1.2 Global Hepatitis Testing Diagnosis Revenue by Manufacturer (2017-2022)
      • 4.1.3 Global Hepatitis Testing Diagnosis Sales by Manufacturer (2017-2022)
      • 4.1.4 Global Hepatitis Testing Diagnosis Price by Manufacturer (2017-2022)
    • 4.2 Global Hepatitis Testing Diagnosis Concentration Ratio (CR)
      • 4.2.1 Hepatitis Testing Diagnosis Market Concentration Ratio (CR) (2017-2022)
      • 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Hepatitis Testing Diagnosis in 2021
      • 4.2.3 Global Hepatitis Testing Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.3 Global Hepatitis Testing Diagnosis Manufacturing Base Distribution, Product Type
      • 4.3.1 Global Hepatitis Testing Diagnosis Manufacturers, Headquarters and Distribution of Producing Region
      • 4.3.2 Manufacturers Hepatitis Testing Diagnosis Product Type
      • 4.3.3 Date of International Manufacturers Enter into Hepatitis Testing Diagnosis Market
    • 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 4.5 United States Hepatitis Testing Diagnosis Market Size by Company
      • 4.5.1 Top Hepatitis Testing Diagnosis Players in United States, Ranked by Revenue (2021)
      • 4.5.2 United States Hepatitis Testing Diagnosis Revenue by Players (2020, 2021 & 2022)
      • 4.5.3 United States Hepatitis Testing Diagnosis Sales by Players (2020, 2021 & 2022)

    5 Global Hepatitis Testing Diagnosis Market Size by Region

    • 5.1 Global Hepatitis Testing Diagnosis Market Size by Region: 2017 VS 2022 VS 2028
    • 5.2 Global Hepatitis Testing Diagnosis Market Size in Volume by Region (2017-2028)
      • 5.2.1 Global Hepatitis Testing Diagnosis Sales in Volume by Region: 2017-2022
      • 5.2.2 Global Hepatitis Testing Diagnosis Sales in Volume Forecast by Region (2023-2028)
    • 5.3 Global Hepatitis Testing Diagnosis Market Size in Value by Region (2017-2028)
      • 5.3.1 Global Hepatitis Testing Diagnosis Sales in Value by Region: 2017-2022
      • 5.3.2 Global Hepatitis Testing Diagnosis Sales in Value by Region: 2023-2028

    6 Segment in Region Level & Country Level

    • 6.1 North America
      • 6.1.1 North America Hepatitis Testing Diagnosis Market Size YoY Growth 2017-2028
      • 6.1.2 North America Hepatitis Testing Diagnosis Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.1.3 United States
      • 6.1.4 Canada
    • 6.2 Asia-Pacific
      • 6.2.1 Asia-Pacific Hepatitis Testing Diagnosis Market Size YoY Growth 2017-2028
      • 6.2.2 Asia-Pacific Hepatitis Testing Diagnosis Market Facts & Figures by Region (2017, 2022 & 2028)
      • 6.2.3 China
      • 6.2.4 Japan
      • 6.2.5 South Korea
      • 6.2.6 India
      • 6.2.7 Australia
      • 6.2.8 China Taiwan
      • 6.2.9 Indonesia
      • 6.2.10 Thailand
      • 6.2.11 Malaysia
    • 6.3 Europe
      • 6.3.1 Europe Hepatitis Testing Diagnosis Market Size YoY Growth 2017-2028
      • 6.3.2 Europe Hepatitis Testing Diagnosis Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.3.3 Germany
      • 6.3.4 France
      • 6.3.5 U.K.
      • 6.3.6 Italy
      • 6.3.7 Russia
    • 6.4 Latin America
      • 6.4.1 Latin America Hepatitis Testing Diagnosis Market Size YoY Growth 2017-2028
      • 6.4.2 Latin America Hepatitis Testing Diagnosis Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.4.3 Mexico
      • 6.4.4 Brazil
      • 6.4.5 Argentina
      • 6.4.6 Colombia
    • 6.5 Middle East and Africa
      • 6.5.1 Middle East and Africa Hepatitis Testing Diagnosis Market Size YoY Growth 2017-2028
      • 6.5.2 Middle East and Africa Hepatitis Testing Diagnosis Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.5.3 Turkey
      • 6.5.4 Saudi Arabia
      • 6.5.5 UAE

    7 Company Profiles

    • 7.1 F. Hoffmann-La Roche
      • 7.1.1 F. Hoffmann-La Roche Corporation Information
      • 7.1.2 F. Hoffmann-La Roche Description and Business Overview
      • 7.1.3 F. Hoffmann-La Roche Hepatitis Testing Diagnosis Sales, Revenue and Gross Margin (2017-2022)
      • 7.1.4 F. Hoffmann-La Roche Hepatitis Testing Diagnosis Products Offered
      • 7.1.5 F. Hoffmann-La Roche Recent Development
    • 7.2 Abbott Laboratories
      • 7.2.1 Abbott Laboratories Corporation Information
      • 7.2.2 Abbott Laboratories Description and Business Overview
      • 7.2.3 Abbott Laboratories Hepatitis Testing Diagnosis Sales, Revenue and Gross Margin (2017-2022)
      • 7.2.4 Abbott Laboratories Hepatitis Testing Diagnosis Products Offered
      • 7.2.5 Abbott Laboratories Recent Development
    • 7.3 Siemens Healthineers AG
      • 7.3.1 Siemens Healthineers AG Corporation Information
      • 7.3.2 Siemens Healthineers AG Description and Business Overview
      • 7.3.3 Siemens Healthineers AG Hepatitis Testing Diagnosis Sales, Revenue and Gross Margin (2017-2022)
      • 7.3.4 Siemens Healthineers AG Hepatitis Testing Diagnosis Products Offered
      • 7.3.5 Siemens Healthineers AG Recent Development
    • 7.4 Bio-Rad Laboratories
      • 7.4.1 Bio-Rad Laboratories Corporation Information
      • 7.4.2 Bio-Rad Laboratories Description and Business Overview
      • 7.4.3 Bio-Rad Laboratories Hepatitis Testing Diagnosis Sales, Revenue and Gross Margin (2017-2022)
      • 7.4.4 Bio-Rad Laboratories Hepatitis Testing Diagnosis Products Offered
      • 7.4.5 Bio-Rad Laboratories Recent Development
    • 7.5 Danaher Corporation
      • 7.5.1 Danaher Corporation Corporation Information
      • 7.5.2 Danaher Corporation Description and Business Overview
      • 7.5.3 Danaher Corporation Hepatitis Testing Diagnosis Sales, Revenue and Gross Margin (2017-2022)
      • 7.5.4 Danaher Corporation Hepatitis Testing Diagnosis Products Offered
      • 7.5.5 Danaher Corporation Recent Development
    • 7.6 QIAGEN
      • 7.6.1 QIAGEN Corporation Information
      • 7.6.2 QIAGEN Description and Business Overview
      • 7.6.3 QIAGEN Hepatitis Testing Diagnosis Sales, Revenue and Gross Margin (2017-2022)
      • 7.6.4 QIAGEN Hepatitis Testing Diagnosis Products Offered
      • 7.6.5 QIAGEN Recent Development
    • 7.7 BioMerieux SA
      • 7.7.1 BioMerieux SA Corporation Information
      • 7.7.2 BioMerieux SA Description and Business Overview
      • 7.7.3 BioMerieux SA Hepatitis Testing Diagnosis Sales, Revenue and Gross Margin (2017-2022)
      • 7.7.4 BioMerieux SA Hepatitis Testing Diagnosis Products Offered
      • 7.7.5 BioMerieux SA Recent Development
    • 7.8 DiaSorin S.P.A.
      • 7.8.1 DiaSorin S.P.A. Corporation Information
      • 7.8.2 DiaSorin S.P.A. Description and Business Overview
      • 7.8.3 DiaSorin S.P.A. Hepatitis Testing Diagnosis Sales, Revenue and Gross Margin (2017-2022)
      • 7.8.4 DiaSorin S.P.A. Hepatitis Testing Diagnosis Products Offered
      • 7.8.5 DiaSorin S.P.A. Recent Development
    • 7.9 Ortho Clinical Diagnostics
      • 7.9.1 Ortho Clinical Diagnostics Corporation Information
      • 7.9.2 Ortho Clinical Diagnostics Description and Business Overview
      • 7.9.3 Ortho Clinical Diagnostics Hepatitis Testing Diagnosis Sales, Revenue and Gross Margin (2017-2022)
      • 7.9.4 Ortho Clinical Diagnostics Hepatitis Testing Diagnosis Products Offered
      • 7.9.5 Ortho Clinical Diagnostics Recent Development
    • 7.10 MedMira Inc
      • 7.10.1 MedMira Inc Corporation Information
      • 7.10.2 MedMira Inc Description and Business Overview
      • 7.10.3 MedMira Inc Hepatitis Testing Diagnosis Sales, Revenue and Gross Margin (2017-2022)
      • 7.10.4 MedMira Inc Hepatitis Testing Diagnosis Products Offered
      • 7.10.5 MedMira Inc Recent Development
    • 7.11 Fujirebio
      • 7.11.1 Fujirebio Corporation Information
      • 7.11.2 Fujirebio Description and Business Overview
      • 7.11.3 Fujirebio Hepatitis Testing Diagnosis Sales, Revenue and Gross Margin (2017-2022)
      • 7.11.4 Fujirebio Hepatitis Testing Diagnosis Products Offered
      • 7.11.5 Fujirebio Recent Development
    • 7.12 Grifols
      • 7.12.1 Grifols Corporation Information
      • 7.12.2 Grifols Description and Business Overview
      • 7.12.3 Grifols Hepatitis Testing Diagnosis Sales, Revenue and Gross Margin (2017-2022)
      • 7.12.4 Grifols Products Offered
      • 7.12.5 Grifols Recent Development
    • 7.13 Orasure Technologies
      • 7.13.1 Orasure Technologies Corporation Information
      • 7.13.2 Orasure Technologies Description and Business Overview
      • 7.13.3 Orasure Technologies Hepatitis Testing Diagnosis Sales, Revenue and Gross Margin (2017-2022)
      • 7.13.4 Orasure Technologies Products Offered
      • 7.13.5 Orasure Technologies Recent Development
    • 7.14 GenMark Diagnostics
      • 7.14.1 GenMark Diagnostics Corporation Information
      • 7.14.2 GenMark Diagnostics Description and Business Overview
      • 7.14.3 GenMark Diagnostics Hepatitis Testing Diagnosis Sales, Revenue and Gross Margin (2017-2022)
      • 7.14.4 GenMark Diagnostics Products Offered
      • 7.14.5 GenMark Diagnostics Recent Development
    • 7.15 Vela Diagnostics
      • 7.15.1 Vela Diagnostics Corporation Information
      • 7.15.2 Vela Diagnostics Description and Business Overview
      • 7.15.3 Vela Diagnostics Hepatitis Testing Diagnosis Sales, Revenue and Gross Margin (2017-2022)
      • 7.15.4 Vela Diagnostics Products Offered
      • 7.15.5 Vela Diagnostics Recent Development
    • 7.16 Epitope Diagnostics
      • 7.16.1 Epitope Diagnostics Corporation Information
      • 7.16.2 Epitope Diagnostics Description and Business Overview
      • 7.16.3 Epitope Diagnostics Hepatitis Testing Diagnosis Sales, Revenue and Gross Margin (2017-2022)
      • 7.16.4 Epitope Diagnostics Products Offered
      • 7.16.5 Epitope Diagnostics Recent Development
    • 7.17 Trivitron Healthcare
      • 7.17.1 Trivitron Healthcare Corporation Information
      • 7.17.2 Trivitron Healthcare Description and Business Overview
      • 7.17.3 Trivitron Healthcare Hepatitis Testing Diagnosis Sales, Revenue and Gross Margin (2017-2022)
      • 7.17.4 Trivitron Healthcare Products Offered
      • 7.17.5 Trivitron Healthcare Recent Development
    • 7.18 Meril Life Sciences
      • 7.18.1 Meril Life Sciences Corporation Information
      • 7.18.2 Meril Life Sciences Description and Business Overview
      • 7.18.3 Meril Life Sciences Hepatitis Testing Diagnosis Sales, Revenue and Gross Margin (2017-2022)
      • 7.18.4 Meril Life Sciences Products Offered
      • 7.18.5 Meril Life Sciences Recent Development
    • 7.19 geneOmbio Technologies
      • 7.19.1 geneOmbio Technologies Corporation Information
      • 7.19.2 geneOmbio Technologies Description and Business Overview
      • 7.19.3 geneOmbio Technologies Hepatitis Testing Diagnosis Sales, Revenue and Gross Margin (2017-2022)
      • 7.19.4 geneOmbio Technologies Products Offered
      • 7.19.5 geneOmbio Technologies Recent Development
    • 7.20 Molbio Diagnostics
      • 7.20.1 Molbio Diagnostics Corporation Information
      • 7.20.2 Molbio Diagnostics Description and Business Overview
      • 7.20.3 Molbio Diagnostics Hepatitis Testing Diagnosis Sales, Revenue and Gross Margin (2017-2022)
      • 7.20.4 Molbio Diagnostics Products Offered
      • 7.20.5 Molbio Diagnostics Recent Development

    8 Industry Chain and Sales Channels Analysis

    • 8.1 Hepatitis Testing Diagnosis Industry Chain Analysis
    • 8.2 Hepatitis Testing Diagnosis Key Raw Materials
      • 8.2.1 Key Raw Materials
      • 8.2.2 Hepatitis Testing Diagnosis Distributors
    • 8.3 Hepatitis Testing Diagnosis Production Mode & Process
    • 8.4 Hepatitis Testing Diagnosis Sales and Marketing
      • 8.4.1 Hepatitis Testing Diagnosis Sales Channels
      • 8.4.2 Hepatitis Testing Diagnosis Distributors
    • 8.5 Hepatitis Testing Diagnosis Customers

    9 Research Findings and Conclusion

      10 Appendix

      • 10.1 Research Methodology
        • 10.1.1 Methodology/Research Approach
        • 10.1.2 Data Source
      • 10.2 Author Details

      Summary:
      Get latest Market Research Reports on Hepatitis Testing Diagnosis. Industry analysis & Market Report on Hepatitis Testing Diagnosis is a syndicated market report, published as Global and United States Hepatitis Testing Diagnosis Market Report & Forecast 2022-2028. It is complete Research Study and Industry Analysis of Hepatitis Testing Diagnosis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,850.00
      $7,700.00
      3,068.45
      6,136.90
      3,580.50
      7,161.00
      588,588.00
      1,177,176.00
      321,205.50
      642,411.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report